Investors

Discover Virbac's Statement on extra-financial performance

SALES 2023
1,247 M€
59%
Companion
animals
41%
Farm
animals

(in € million)

Financial public release
& News

2024 fourth quarter consolidated sales

2025/01/16 - Financial public releases

Strong annual revenue growth of +13.6% supported by dynamic organic growth (+7.5%) and the strategic contribution of our acquisitions (+6.1%)

Read more

Türkiye: Virbac acquires its companion animal products distributor

2024/12/03 - Financial public releases

Vignette_corpo_Byzance.jpgOn December 2, we finalized the acquisition of Turkish company Mopsan, specialized in the distribution of petfood and companion animal health products.

Read more

2024 third quarter consolidated sales

2024/10/17 - Financial public releases

Strong revenue growth as of the end of September at +12.6% and +8.6% at constant exchange rates and scope. 2024 targets maintained.

Read more

Events
Thursday March 13

2024 results

From 2025/03/13

Read moreRead less

Thursday March 13, 2024 after market close

2024 results
(quiet period from February 13, 2025)​

Friday March 14

SFAF meeting - 2024 financial & strategic information

From 2025/03/14

Read moreRead less

Friday March 14, 2025
SFAF meeting - 2024 financial & strategic information
Tuesday April 15

2025 first quarter sales

From 2025/04/15

Read moreRead less

Tuesday April 15, 2025 after market close

2025 first quarter sales
(quiet period from April 1, 2024)

For more financial information

For more financial information

finances@virbac.com